Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP)
Go back to Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP)| R & A Productions, Inc. Common (NASDAQ: RAPP) | Delayed: 40.59 -1.16 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.75 | 52 Week High | $3.75 | |||
| Open | $41.12 | 52 Week Low | $0.25 | |||
| Day High | $42.66 | P/E | 4,059.00 | |||
| Day Low | $39.62 | EPS | $0.01 | |||
| Volume | 364,527 | |||||
